Nabumetone Tablet
Product Images NDC 72189-072

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 72189-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72189 0184 14

NABUMETONE 500 mg oral tablet bottle label containing 14 tablets. The label states the product is generic for RELAFEN and contains Nabumetone USP 500 mg. It includes lot number, discard date, and packaging/distribution information by Direct Rx. The label also has instructions to keep out of reach of children.*

FDA Label Image

072 (72189 072 30)

NABUMETONE 750 mg oral tablets label from direct rx. The packaging shows 30 tablets per bottle. It is labeled as generic for RELAFEN, with each tablet containing 750 mg of nabumetone. Lot number 23JA2004 and discard date 9/30/21 are visible, along with manufacturing details and NDC 72189-072-30. Additional labeling includes batch and manufacturer codes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.